Guardant Health is a pioneer in non-invasive cancer diagnostics and the first company to commercialize a comprehensive genomic liquid biopsy. The Company's proprietary digital sequencing technology is transforming cancer treatment by providing an accurate and precise picture of the individual genomic alterations that cause tumors to grow, change, and develop resistance to treatment.
Latest funding size
Time since last funding
|about 2 months|
|Sequoia Capital, Khosla Ventures, Heritage Group, Temasek Holdings, Bobby Yazdani, Felicis Venture, Softbank, OrbiMed, OrbiMed Advisors, Pejman Mar Ventures, Formation 8, Lightspeed Venture Partners, T. Rowe Price, 8VC|